Market Closed -
Japan Exchange
11:30:00 08/05/2024 am IST
5-day change
1st Jan Change
2,249
JPY
-0.66%
-0.53%
+1.63%
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
February 08, 2021 at 07:00 am IST
From February 5, 2021 to February 8, 2021, the company has repurchased 100,000 shares, representing 0.5% for ¥274.8 million. With this, the company has completed the repurchase of 100,000 shares, representing 0.5% for ¥274.8 million under the buyback announced on February 5, 2021.
WDB Holdings Co., Ltd. Announces the Resignation of Shuji Kondo as Managing Director, Effective from March 31, 2024
15/03
CI
TerrAscend Announced $37 Million Paydown of Senior Secured Term Loan in Pennsylvania
30/23/30
MT
WDB Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
12/23/12
CI
TerrAscend Cuts Outstanding Debt
30/22/30
MT
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.
14/22/14
CI
WDB Holdings Co., Ltd.'s Equity Buyback announced on November 11, 2022, has closed with 100,000 shares, representing 0.51% for ¥258.3 million.
14/22/14
CI
WDB Holdings Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.51% for ¥300 million.
11/22/11
CI
WDB Holdings Co., Ltd. authorizes a Buyback Plan.
11/22/11
CI
An unknown buyer completed the acquisition of Kaken Geneqs Inc. from WDB Holdings Co., Ltd..
25/22/25
CI
An unknown buyer agreed to acquire Kaken Geneqs Inc. from WDB Holdings Co., Ltd. for approximately ¥200 million.
20/22/20
CI
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
08/21/08
CI
WDB Holdings Co., Ltd.'s Equity Buyback announced on February 5, 2021, has closed with 100,000 shares, representing 0.5% for ¥274.8 million.
08/21/08
CI
WDB Holdings Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.5% for ¥300 million.
05/21/05
CI
WDB Holdings Co., Ltd. authorizes a Buyback Plan.
05/21/05
CI
Nakano Shoten Co., Ltd cancelled the acquisition of 9.7% stake in WDB Holdings Co., Ltd. from Toshimitsu Nakano.
08/20/08
CI
Wdb Holdings Co., Ltd. Reports Consolidated Earnings Results for the Third Quarter of 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020
07/20/07
CI
WDB coco Co., Ltd. has completed an IPO in the amount of ¥875.16 million.
24/19/24
CI
WDB coco Co., Ltd. has filed an IPO.
20/19/20
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the Second Quarter Ended September 30, 2019; Provides Earnings Guidance for the Year Ending March 31, 2020
08/19/08
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the Second Quarter and Fiscal Year 2020
09/19/09
CI
Nakano Shoten Co., Ltd agreed to acquire 9.7% stake in WDB Holdings Co., Ltd. from Toshimitsu Nakano.
08/19/08
CI
An unknown buyer completed the acquisition of WDB Environmental & Biological Research Institute Co., Ltd. from WDB Holdings Co., Ltd..
31/18/31
CI
An unknown buyer signed a contract to acquire WDB Environmental & Biological Research Institute co., Ltd. from WDB Holdings Co., Ltd..
07/18/07
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the Fiscal Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Second Quarter and Fiscal Year Ending March 31, 2019
11/18/11
CI
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on February 9, 2018.
14/18/14
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
WDB HOLDINGS CO., LTD. is a company mainly engaged in the manpower dispatching business. The Company operates in two business segments. The Human Resource Service segment is engaged in the work of client customers mainly through temporary staffing and contracting contracts. The CRO (Contract Research Organization) business segment acts on and supports experimental work in basic research of pharmaceuticals, quasi-drugs, cosmetics and development work after clinical trial. The other business is engaged in the contracted manufacture of organic chemicals, as well as the product development and sale, and the research of the aquaculture and breeding of clams, fishes and algae, among others.
More about the company
Last Close Price
2,264
JPY
Average target price
3,300
JPY
Spread / Average Target
+45.76%
Consensus
1st Jan change
Capi.
+1.63% 288M -15.64% 9.06B -20.40% 7.22B -20.23% 5.92B -3.06% 3.68B -8.63% 3.2B +12.17% 1.65B +0.83% 1.53B +10.92% 1.51B -5.79% 1.19B
Other Employment Services
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
WDB HOLDINGS CO., LTD. 
